Brevan Howard Capital Management LP Agios Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 16,336 shares of AGIO stock, worth $686,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,336
Previous 18,544
11.91%
Holding current value
$686,438
Previous $412,000
15.78%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$235 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$234 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$196 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$168 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$132 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.3B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...